Mutual of America Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Mutual of America Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,311	Closed	-$2.31M	–	1484
2023 Q4	$2.31M	Sell	7,311 -335	-4%	-$65.1K	0.03%	841
2023 Q3	$1.29M	Sell	7,646 -8,535	-53%	-$1.6M	0.02%	997
2023 Q2	$3.51M	Sell	16,181 -1,220	-7%	-$261K	0.04%	653
2023 Q1	$3.16M	Buy	17,401 +866	+5%	+$166K	0.04%	717
2022 Q4	$3.25M	Buy	16,535 +4,657	+39%	+$999K	0.04%	689
2022 Q3	$2.67M	Buy	+11,878	New	+$2.4M	0.04%	714

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Mutual of America Capital Management's KRTX Position: Q1 2024 in Review

Mutual of America Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 7,311 shares — an estimated $2.31M sold.

Mutual of America Capital Management first reported a position in KRTX in Q3 2022 and held it in 6 quarters. The position peaked at $3.51M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Mutual of America Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Mutual of America Capital Management sold 7,311 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.31M.
Mutual of America Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
Mutual of America Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $3.51M in Q2 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Mutual of America Capital Management's 13F filing for Q1 2024, filed 2 May 2024.